Crinetics (NASDAQ: CRNX) CEO reports 1.94M share gifts and trust transfers
Rhea-AI Filing Summary
Crinetics Pharmaceuticals President & CEO Richard Scott Struthers reported a series of estate and charitable planning moves involving gifts of 1,937,600 shares of common stock on May 29, 2026. The transactions are coded as bona fide gifts, with reported prices of $0.0000 per share, indicating no sale proceeds.
The gifts include transfers among multiple family trusts, a charitable remainder trust, and his spouse, with the filing noting that he disclaims beneficial ownership of certain trust-held shares except for his pecuniary interest. Following these transactions, he continues to hold significant positions, including 626,978 shares directly and 439,005 shares indirectly through Family Trust 1.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Gift | Common Stock | 222,200 | $0.00 | $0.00 |
| Gift | Common Stock | 222,200 | $0.00 | $0.00 |
| Gift | Common Stock | 80,000 | $0.00 | $0.00 |
| Gift | Common Stock | 222,200 | $0.00 | $0.00 |
| Gift | Common Stock | 222,200 | $0.00 | $0.00 |
| Gift | Common Stock | 80,000 | $0.00 | $0.00 |
| Gift | Common Stock | 111,100 | $0.00 | $0.00 |
| Gift | Common Stock | 111,100 | $0.00 | $0.00 |
| Gift | Common Stock | 111,100 | $0.00 | $0.00 |
| Gift | Common Stock | 111,100 | $0.00 | $0.00 |
| Gift | Common Stock | 111,100 | $0.00 | $0.00 |
| Gift | Common Stock | 111,100 | $0.00 | $0.00 |
| Gift | Common Stock | 111,100 | $0.00 | $0.00 |
| Gift | Common Stock | 111,100 | $0.00 | $0.00 |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (3)
- F1. (1) Represents gifts of shares by the Struthers Family Trust ("Family Trust 1"), of which the Reporting Person is the trustee and the Reporting Person and his spouse are beneficiaries, to (a) the Reporting Person, (b) the Reporting Person's spouse and (c) the Struthers Family Charitable Remainder Trust (the "Charitable Trust"), a charitable remainder trust of which the Reporting Person is the trustee and of which the Reporting Person and his spouse are beneficiaries. The Reporting Person disclaims beneficial ownership of the shares held by the Charitable Trust except to the extent of his pecuniary interest therein.
- F2. (2) Represents contributions of shares by the Reporting Person to (a) the GMS Dynasty Trust ("Family Trust 5") and (b) the JSS Dynasty Trust ("Family Trust 6"), each of which is an irrevocable trust with an independent trustee of which the Reporting Person's spouse and her family members, and the Reporting Person's spouse, respectively, are beneficiaries. The Reporting Person disclaims beneficial ownership of the shares held by Family Trust 5 and Family Trust 6 except to the extent of his pecuniary interest therein.
- F3. (3) Represents contributions of shares by the Reporting Person's spouse to (a) the Iowa Descendants Trust ("Family Trust 7") and (b) the RSS Dynasty Trust ("Family Trust 8"), each of which is an irrevocable trust with an independent trustee of which the Reporting Person and his family members are beneficiaries. The Reporting Person disclaims beneficial ownership of the shares held by Family Trust 5 and Family Trust 6 except to the extent of his pecuniary interest therein.
Key Figures
Key Terms
bona fide gift financial
Charitable Remainder Trust financial
irrevocable trust financial
pecuniary interest financial
beneficial ownership financial
AI-generated analysis. How Rhea-AI works. Not financial advice.